FDA Drug Application (202843) for MONTELUKAST SODIUM by HETERO LABS LTD V

Back to FDA Applications sponsored by HETERO LABS LTD V

Application Number202843
Product Number001
FormTABLET;ORAL
DosageEQ 10MG BASE
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameMONTELUKAST SODIUM
Active IngredientMONTELUKAST SODIUM



Back to FDA Applications sponsored by HETERO LABS LTD V

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.